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Background: Paraquat is a highly toxic herbicide, which not only leads to acute organ damage, but also to
pulmonary fibrosis. There are only anecdotal reports of rescue lung transplantation, as paraquat is stored and only
slowly released from different tissues. Bridging the time to complete depletion of paraquat from the body could
render this exceptional therapy strategy possible, but not much is known on the time interval after which
transplantation can safely be performed.
Case presentation: We report on a case of accidental paraquat poisoning in a 23 years old Caucasian man, who
developed respiratory failure due to pulmonary fibrosis. The patient was listed for high urgency lung transplantion,
and extracorporeal membrane oxygenation was implemented to bridge the time to transplantation. The patient
died 32 days after paraquat ingestion, before a suitable donor organ was found. In postmortem tissue specimen, no
paraquat was detectable anymore.
Conclusion: This case report indicates that complete elimination of paraquat after oral ingestion of a lethal dose is
achievable. The determined time frame for this complete elimination might be relevant for patients, in which lung
transplantation is considered.
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Paraquat (1,1’-dimethyl-4,4’ bipyridinium dichloride) is a
highly toxic contact herbicide, which has been banned in
Germany since 2007. However, there are still rare cases
of paraquat intoxications with leftovers of paraquat pur-
chased prior to the ban, mostly in form of suicide at-
tempts. After oral ingestion, the intestinal absorption of
paraquat is poor (1-5%), but still sufficient to elicit a
severe and potentially fatal intoxication. Early toxicity
includes oral, pharyngeal and gastrointestinal ulcerations
and necroses, acute kidney injury and liver failure [1].* Correspondence: bertram.anna@mh-hannover.de
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reproduction in any medium, provided the orIngestion of two or more mouthful of paraquat usually
leads to circulatory failure within two days, whereas
patients, who swallow not more than one mouthful,
often survive the early phase of paraquat intoxication
[2]. Late toxicity is mostly due to the storage of paraquat
in alveolar macrophages, where it reacts with the highly
abundant oxygen to form radicals and reactive oxygen
species. The reactions of paraquat simultaneously de-
plete the body of antioxidants [3]. The consequences are
pulmonary inflammation and fibrosis, which is the main
cause of death in patients surviving the early phase of
paraquat poisoning. In case of attempted suicide, the
psychiatric background does not allow lung transplant-
ation. In accidental paraquat ingestion, however, lung
transplantation could be the only therapeutic strategy, if itl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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the body to prevent recurrence of fibrosis in the allograft.
The first attempt of lung transplantation in paraquat in-
toxication in 1968 failed as the single lung transplantation
was performed as early as 7 days after intoxication of a
15 years old boy [4]. Due to recurrence of fibrosis in the
allograft, these authors speculated already that paraquat
stored in the tissue caused fibrosis of the allograft. Hence,
complete depletion of paraquat from the body to prevent
fibrosis of the allograft due to redistribution of paraquat
from the tissue is necessary. After what time this complete
depletion would occur is unknown. Yet the first successful
lung transplantation reported by Walder et al. [5] was
performed 44 days after intoxication. Here, we report on a
case of accidental paraquat intoxication, in which we
attempted to bridge the time to transplantation with extra-
corporeal membrane oxygenation.Figure 1 Clinical course. A) Paraquat serum and urine levels over time. Se
unfavourable outcome [6]. The low serum values on day 3 and 4 reflect po
therapeutic interventions (HD: hemodialysis; CYC: cyclophosphamide).Case presentation
A 23 years old Caucasian man was admitted to a local
hospital after reporting that he had accidentally
ingested paraquat. Allegedly he had filled the paraquat
(Gramoxone®, 20% [weight/volume]) into a soda bottle
a few days before in order to facilitate the dosing of the
herbicide at his job as a gardener, avoiding the use of
the industrial size original container. On a Monday
morning he confused the bottle with the paraquat ali-
quot with a real soda bottle and accidentally swallowed
one mouthful, which probably accounts for an ingested
amount of paraquat of 6–10 g. He immediately pro-
voked emesis and presented to the nearest emergency
room. There, a gastric lavage was performed, 40 g of
activated charcoal were administered and paraquat levels
in serum (2.12 mg/l) and urine (350.00 mg/l) were deter-
mined (Figure 1A), suggesting that the ingested amount ofrum levels exceeding 0.6 mg/l at 6 h or 0.1 mg/l at 24 h predict an
st-dialysis values. B) Arterial partial oxygen tension and flow chart of
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non-oliguric kidney injury within 48 h, which is another
known sign indicating a fatal outcome [7], the patient was
transferred to our tertiary care centre for further treat-
ment. At this time, the patient did not report any short-
ness of breath, nausea, pain or impaired diuresis. Physical
examination revealed mild jaundice and swelling and
redness of the throat. Laryngoscopy showed redness and
necroses of the hypopharynx, the epiglottis and the vocal
cords. Otherwise, physical examination was unremarkable,
with normal findings for chest and abdominal examination
and a normal chest X-ray (Figure 2A). Forced vital cap-
acity was reduced to 38% predicted on day 4, the alveolar-
arterial oxygen gradient was 34 mmHg. Laboratory values
revealed pathological liver function tests, mildly elevated
inflammatory parameters and acute kidney injury (Table 1),
so daily hemodialysis was started. Using the GENIUS®
system with a sleddFlux dialysator (Fresenius Medical
Care GmbH, Bad Homburg, Germany) and a blood flow
of 300 ml/min, a paraquat clearance of 122 ml/min was
achieved. No paraquat (i.e., < 0.01 mg/l) was detectable
in the collected spent dialysate. In addition, a therapy
with methylprednisolone (5 × 1 g i.v.) and cyclophos-
phamide (15 mg/kg bodyweight per day i.v. for two
days) was started to delay the development of pulmonary
fibrosis [8]. Additionally, we initiated treatment with tam-
oxifen (3 × 20 mg p.o.), for which a hormone-independent
antiproliferative and anti-inflammatory effect is well
known in retroperitoneal fibrosis [9]. However, 72 hFigure 2 Progressive pulmonary fibrosis. Chest X-ray (A-C) and comput
fibrosis on day 3 (A), 9 (B), and 12 (C).after paraquat ingestion, desaturation occured, and the
patient had to be transferred to the medical intensive
care unit. Due to progressive respiratory failure, oxygen
supplementation had to be started despite its potentially
enhancing effect on paraquat toxicity [3]. On the 9th
day after paraquat ingestion, invasive ventilation became
necessary due to the progression of pulmonary fibrosis
(Figure 2B). Because of the convincing negation of a sui-
cidal attempt, confirmed by repeated psychiatric evalu-
ation, we decided to list the patient for high urgency
double lung transplantation. The patient’s condition
worsened progressively with development of a systemic
inflammatory response syndrome. On his 12th hospital
day, FiO2 had to be increased from 50 to 100% due to
deteriorated oxygenation, and a veno-venous extracorpor-
eal membrane oxygenation (vvECMO) was implemented
(Figure 2C-D). Even with maximum support by vvECMO,
multiple drastic declines in gas exchange led to hemo-
dynamic instability, so that the veno-venous system had to
be switched to veno-arterial ECMO (vaECMO) on the
20th day. After initial stabilization on a poor clinical level,
septic multiorgan dysfunction with kidney, liver and
hemodynamic failure developed from the 29th day on.
Thirty-two days after paraquat ingestion, the patient died
from cardiac failure with pulseless electrical activity. An
autopsy was performed, showing fibrotic remodelling of
the lungs and ubiquitous signs of shock, such as swelling
of the brain, liver and kidneys. Postmortem tissue speci-
mens were examined for paraquat levels (Table 2). For thised tomography (D; 11th day) demonstrating progressive pulmonary
Table 1 Laboratory values after referral (3rd day after
paraquat ingestion); pathological values are bold
Parameter Measured value Standard value
Leukocytes 17.7 / nl 4.4 – 11.3 / nl
Erythrocytes 4.65 / fl 4.50 – 5.90 / fl
Hemoglobin 14.5 g/dl 13.5 – 17.5 g/dl
MCV 84.5 fl 80 – 100 fl
MCH 31.2 pg 26 – 34 pg
MCHC 36.9 g/dl 31 – 37 g/dl
INR 1.17 0.9 – 1.25
aPTT 26 sec 26 – 35 sec
s-potassium 3.8 mmol/l 3.6 – 5.4 mmol/l
s-sodium 130 mmol/l 138 – 148 mmol/l
s-chloride 90 mmol/l 97 – 108 mmol/l
s-calcium 2.41 mmol/l 2.15 – 2.60 mmol/l
s-phosphate 1.60 mmol/l 0.83 – 1.67 mmol/l
s-CRP 10 mg/l < 8 mg/l
s-creatinine 387 μmol/l 59 – 104 μmol/l
s-urea 18.2 mmol/l 3.3 – 6.7 mmol/l
s-CK 138 U/l < 171 U/l
s-AST 697 U/l < 35 U/l
s-ALT 1030 U/l < 45 U/l
s-GLDH 601 U/l < 7 U/l
s-AP 138 U/l 40 – 129 U/l
s-γGT 441 U/l < 55 U/l
s-CHE 6.08 U/l 5.32 – 12.91 U/l
s-LDH 393 U/l < 248 U/l
s-bilirubin 75 μmol/l < 17 μmol/l
Table 2 Paraquat levels in different tissues / materials
Tissue / material Paraquat level
Bronchoalveolar lavage < 0.01 mg/l*
Muscle biopsy < 0.2 μg/g*
Fat biopsy < 0.2 μg/g*
Autopsy tissue specimens
Brain < 0.2 μg/g
Bone marrow < 0.2 μg/g
Heart < 0.2 μg/g
Kidney < 0.2 μg/g
Liver < 0.2 μg/g
Lung < 0.2 μg/g
Spleen < 0.2 μg/g
Thyroid gland < 0.2 μg/g
Pancreas < 0.2 μg/g
Bowel < 0.2 μg/g
Bile < 0.2 μg/g
*17 d after paraquat ingestion.
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mogenized, extracted with perchloric acid and neutralized.
After pre-purification, paraquat levels in extracts or serum
samples were quantified by reverse-phase HPLC and UV
detection at 270 nm with a detection limit of 0.01 mg/l for
serum and 0.2 μg/g for processed tissues (intraassay
imprecision 2.4%).
Treatment options in paraquat poisoning are limited.
This holds especially true for the use of extracorporeal
treatment methods, which are currently evaluated in a
standardized approach [10]. Since the main problems
arise from irreversible lung damage, the major goal is to
reduce intestinal absorption and enhance elimination of
paraquat before it can be stored in the tissue. Administra-
tion of activated charcoal and gastric lavages are regularly
performed. However, intestinal absorption of paraquat is a
rapid process and high paraquat plasma levels are reached
within minutes to 4 hours after paraquat ingestion [11].
When our patient came to the hospital approximately 6 h
after paraquat ingestion, serum levels might already havereached their maximum, so charcoal administration and
gastric lavage probably had no effect.
Although paraquat is eliminated by the kidneys, forced
diuresis has no proven benefit on mortality. The early ini-
tiation of charcoal hemoperfusion within the first hours
after paraquat poisoning seems to have a beneficial prog-
nostic effect on survival [12], but the majority of patients
with paraquat poisoning do not benefit from extracorpor-
eal methods including hemoperfusion, hemodialysis or
hemofiltration [13,14]. The reason for that might be that
the ingested paraquat reaches the lungs before renal re-
placement therapy can be implemented. Paraquat is stored
in different tissues, expecially the lung, but also in brain,
liver, kidney, bile and muscle in varying amounts [15-17],
from where it is only released slowly. Finally, immunosup-
pressive therapy regimens and antioxidants [18] have been
used to prevent the development of fibrosis, including
high-dose steroids, cyclophosphamid [8], and sirolimus
[19], with varying success. But even with this aggressive
therapy, pulmonary fibrosis develops in most patients
including ours, so that lung transplantation seems to be
the last option in absence of contraindications. However,
lung transplantation can only be successful, if the body is
completely depleted of paraquat. Otherwise, fibrosis would
potentially recur in the allograft. The first attempt of single
lung transplantation in a case of paraquat poisoning was
reported as early as 1968. The transplantation was
performed seven days after accidental paraquat ingestion,
when there was still paraquat detectable in the patient’s
blood (0.4 mg/l) and the explanted left lung (8.50 μg/g).
Two weeks after the transplantation, the patient died from
respiratory failure. Postmortem histopathology revealed
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native right and the transplanted left lung, indicating a
recurrence of fibrosis caused by paraquat released from its
body stores. At this time, no paraquat could be detected in
both the native and the transplanted lung postmortem,
but other tissues were not examined [4]. Walder et al. [5]
reported the first successful single lung transplantations
performed 44 days after paraquat ingestion. The patients
showed no signs of recurrent pulmonary fibrosis in the
allograft and survived at least one year. However, serum
was free from detectable paraquat levels as early as 4 d
after paraquat ingestion, when serum levels still reached
0.15 mg/l in our patient despite daily hemodialysis.
Our patient was listed for high-urgency lung trans-
plantation, because all of the described treatment strat-
egies failed. We used extracorporeal support to bridge
the time to transplantation, but the patient developed
septic multiorgan failure and finally died before a suit-
able donor organ was available. In postmortem tissue
specimen no paraquat could be detected, suggesting
that lung transplantation would potentially have been
successful. Furthermore, the donation of otherwise un-
damaged organs would have been possible without
endangering the recipient, as has been demonstrated for
corneas in single cases [20].
Conclusions
In a variety of tissue samples obtained postmortem, we
can show that complete elimination paraquat after oral
ingestion of a lethal dose is achievable. The determined
time frame for this complete elimination might be relevant
for patients, in which lung transplantation is considered.
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